- Open Access
Correction to: Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells
Journal of Nanobiotechnology volume 16, Article number: 3 (2018)
- The original article was published in Journal of Nanobiotechnology 2014 12:21
Correction to: Journal of Nanobiotechnology 2014, 12:21 https://doi.org/10.1186/1477-3155-12-21
Following publication of our article , we became aware that Roberto Di Gesù had been omitted from the list of authors. The corrected author list and authors’ contribution statement appear below. We apologize for any inconvenience this may have caused.
Corrected author list
Roberto Di Gesù, Maria Luisa Bondì, Antonina Azzolina, Emanuela Fabiola Craparo, Chiara Botto, Erika Amore, Gaetano Giammona, Melchiorre Cervello
Corrected Authors’ contributions
CB and EA are the Ph.D. students who carried out the laboratory work. AA carried out the biological work in laboratory. MC was the supervisor of the biological study and helping to develop the study parameters and design. RDG performed principal and most important analysis in the chemical and pharmaceutical studies. He produced materials and analyzed data showed in this work. MLB was the principal, scientific supervisor of the study. She conceived the study, supervised the students in the laboratory, directed the analysis and wrote the manuscript. EFC and GG have revised the final version of manuscript. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Di Gesù R, Bondì ML, Azzolina A, Craparo EF, Botto C, Amore E, Giammona G, Cervello M. Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells. Journal of Nanobiotechnology. 2014;12:21.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original article can be found online at https://doi.org/10.1186/1477-3155-12-21.
About this article
Cite this article
Di Gesù, R., Bondì, M.L., Azzolina, A. et al. Correction to: Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells. J Nanobiotechnol 16, 3 (2018). https://doi.org/10.1186/s12951-017-0325-y